Loading organizations...
Baoling Bio is a China-based high-tech enterprise that operates as an innovative research and development service provider and a large-scale manufacturer of biological polysaccharide sugars for various industries. The company pioneered the industrial production of oligosaccharides and erythritol, offering a comprehensive supply chain for functional sugars while also assisting pharmaceutical and biotechnology firms in the discovery, testing, and development of new therapeutics. Operating primarily as a business-to-business service provider and contract research organization, the enterprise generates revenue through fee-for-service research partnerships and the export of its functional sugar products to over 60 countries and regions globally. Baoling Bio has established strategic supply partnerships and research collaborations with several major multinational food, beverage, and dairy corporations, including Coca-Cola, PepsiCo, Kraft, Nestlé, and Yili. The diversified life sciences and manufacturing organization was officially founded in 1997.
Baoling Bio has raised $85.9M across 1 funding round.
Baoling Bio has raised $85.9M in total across 1 funding round.
Baoling Bio has raised $85.9M in total across 1 funding round.
Baoling Bio's investors include Qiming Venture Partners, TrueLight Capital, 5Y Capital, Guosheng Capital.
Baoling Bio has raised $85.9M across 1 funding round. Most recently, it raised $85.9M Series C in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 16, 2026 | $85.9M Series C | Qiming Venture Partners, Truelight Capital | 5Y Capital, Guosheng Capital | Announced |
